ONSET OF ACTION AND TIME TO EFFICACY OF AVANAFIL, A NOVEL, RAPID-ONSET PDE5 INHIBITOR IN MEN WITH MILD TO SEVERE ERECTILE DYSFUNCTION: DATA FROM PHASE 2 AND PHASE 3 CLINICAL TRIALS

被引：1

作者：

Hellstrom, Wayne J. G.

Freier, Matthew T.

Serefoglu, Ege Can

Lewis, Ronald W.

Peterson, Craig A.

DiDonato, Karen

Day, Wesley W.

机构：

来源：

JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期

关键词：

D O I：

10.1016/j.juro.2012.02.2002

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

1480

引用

页码：E600 / E600

页数：1

共 19 条

[1] ONSET OF ACTION AND TIME TO EFFICACY OF AVANAFIL, A NOVEL, RAPID-ONSET PDE5 INHIBITOR IN MEN WITH MILD TO SEVERE ERECTILE DYSFUNCTION: DATA FROM PHASE 2 AND PHASE 3 CLINICAL TRIALS
Hellstrom, Wayne J. G.
Freier, Matthew T.
Serefoglu, Ege Can
Lewis, Ronald W.
Peterson, Craig A.
DiDonato, Karen
Day, Wesley W.
JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 50 - 51
[2] PHARMACOKINETICS OF AVANAFIL; A NOVEL, RAPIDLY-ABSORBED, SELECTIVE PDE5 INHIBITOR FOR THE TREATMENT OF MILD TO SEVERE ERECTILE DYSFUNCTION (ED)
Allison, M.
Grant, T.
Obaidi, M.
Marenco, T.
Yee, S.
Day, W.
JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 466 - 467
[3] ONSET OF ACTION OF AVANAFIL, A NEXT-GENERATION PHOSPHODIESTERASE TYPE 5 INHIBITOR, IN MEN WITH MILD TO SEVERE ERECTILE DYSFUNCTION: DATA FROM AN INTEGRATED ANALYSIS OF THE PHASE2 (TA-05) AND PHASE 3 (TA-301-AND TA-302) STUDIES
Belkoff, L.
Goldstein, I
McCullough, A.
Jones, L. R.
DiDonato, K.
Peterson, C.
Day, W.
JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 248 - 248
[4] Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)
Blauvelt, Andrew
Papp, Kim A.
Lebwohl, Mark G.
Green, Lawrence J.
Hsu, Sylvia
Bhatt, Varsha
Rastogi, Shipra
Pillai, Radhakrishnan
Israel, Robert
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (02) : 372 - 374
[5] Reliable efficacy over time of vardenafil, a potent, selective PDE-5 inhibitor in men with diabetes erectile dysfunction: a retrospective analysis of three Pivotal Phase III Studies
Montorsi, F
Buvat, J
Homering, M
Sprenger, K
Goldstein, I
DIABETOLOGIA, 2004, 47 : A463 - A463
[6] Rapid onset of efficacy in patients with psoriasis treated with ixekizumab: A pooled analysis of data from two phase 3 randomized clinical trials (UNCOVER-2 and UNCOVER-3)
Leonardi, Craig
Langley, Richard
Blauvelt, Andrew
Gordon, Kenneth
Shrom, David
Kerr, Lisa
Stoyko, Ivaylo
Reich, Kristian
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB70 - AB70
[7] Rapid onset of efficacy in patients with psoriasis treated with ixekizumab: A pooled analysis of data from two phase 3 randomized clinical trials (UNCOVER-2 and UNCOVER-3)
Leonardi, C. L.
Langley, R.
Blauvelt, A.
Gordon, K.
Shrom, D. S.
Farmer-Kerr, L. N.
Stoykov, I.
Ojeh, C.
Reich, K.
EXPERIMENTAL DERMATOLOGY, 2017, 26 (03) : E29 - E30
[8] Rapid Onset of Efficacy in Patients with Active Psoriatic Arthritis Treated with Ixekizumab: A Pooled Analysis of Data from Two Phase III Clinical Trials
Deodhar, Atul A.
Papp, Kim A.
Shuler, Catherine
Park, So Young
Kvien, Tore K.
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[9] RAPID ONSET OF EFFICACY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH IXEKIZUMAB: A POOLED ANALYSIS OF DATA FROM TWO PHASE III CLINICAL TRIALS
Deodhar, A.
Papp, K.
Shuler, C. L.
Park, S. Y.
Kvien, T.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 755 - 755
[10] The impact of discussions between men with erectile dysfunction (ED) and their doctors on continuation of PDE5 inhibitor treatment: Subset analysis of men with ED from the multinational men's attitudes to life events and sexuality (males) phase II study
不详
EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 103 - 103

← 1 2 →